Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Propoxycaine is a local anesthetic of the ester type, chemically classified as a para-aminobenzoic acid ester. It functions by reversibly binding to and blocking voltage-gated sodium channels in nerve cells, which inhibits the ionic flux essential for the conduction of nerve impulses. This action leads to a temporary loss of sensation and localized pain relief. Historically, Propoxycaine was primarily utilized in dental procedures and minor surgeries, often in combination with procaine to achieve a more rapid onset and longer duration of anesthetic effect. Although its mechanism of action is well-established, its usage has declined with the advent of newer anesthetics, and it was removed from the US market in 1996.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Propoxycaine.